Berthold Awards Marlene DeLuca Prices

Bad Wildbad, (PresseBox) - Berthold Technologies, specializing in bioanalytical instruments for the research and the diagnostics markets, awarded the Marlene DeLuca prices to four young scientists.

The prices were given at the 17th International Symposium on Bioluminescence and Chemiluminescence to researchers from Japan, Italy, France and the U.S.A. The Marlene DeLuca award - traditionally sponsored by Berthold Technologies - is intended to encourage young scientists and includes a $1,500 donation.

It has been named in honour of Marlene DeLuca who has pioneered the science of bioluminescence and chemiluminescence, one of her many contributions being the first cloning of the firefly luciferase gene.

The recent event took place in Guelph, Canada, and had been hosted by Dr. Luba Brovko, Adjunct Faculty of Food Science.

The four young researchers have been selected for their excellent presentations and results:

Dan Close, University of Tennessee, Knoxville, Center for Environmental Biotechnology: The use of autonomously bioluminescent human cell lines for detection of bacterial contamination.

Kanako Terakado, Kyoto University, Dept. of Structural Biology: Structural basis for colour modulation mechanism of firefly luciferase bioluminescence.

Elisa Michelini, University of Bologna, Dept. of Pharmaceutical Sciences: Whole-cell bioluminescence biosensor for on-site anti-doping screening.

Celine Rosticher, University Pierre et Marie Curie, Paris, Laboratoire Chimie de la Matière Condensée: Synthesis and optical characterization of nanoparticles with persistent luminescence in the red - near infrared range.


Berthold Technologies, a family driven company with its headquarters in Bad Wildbad, Germany, has been providing bioanalytical instruments to the research and the diagnostic market for more than 60 years. The company is offering innovative products through a worldwide network of subsidiaries and distributors to customers in academic and pharmaceutical research as well as clinical diagnostics

Press releases you might also be interested in

Weitere Informationen zum Thema "Biotechnik":

Künstliche Intelligenz entwächst der Experimentierphase

Im Rah­men ei­ner Stu­die hat In­fo­sys un­ter­sucht, wel­che Aus­wir­kun­gen Künst­li­che In­tel­li­genz (KI) in der Pra­xis hat. Da­bei stand vor al­lem der Ein­fluss auf den Re­turn-on-In­vest­ment (ROI), Ar­beit­neh­mer und Füh­rungs­kräf­te im Mit­tel­punkt.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.